FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Mankind Pharma IPO and Udayshivakumar Infra IPO.
Mankind Pharma IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Udayshivakumar Infra IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Mankind Pharma IPO | Udayshivakumar Infra IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Axis Capital Limited Iifl Securities Ltd Jefferies India Private Limited J.P. Morgan India Private Limited |
Saffron Capital Advisors Private Limited |
Registrar | Kfin Technologies Limited | Mas Services Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mankind Pharma IPO is up to ₹4,326.36 Cr whereas the issue size of the Udayshivakumar Infra IPO is up to ₹66.00 Cr. The final issue price of Mankind Pharma IPO is ₹1,080.00 per share and of Udayshivakumar Infra IPO is ₹35.00 per share.
Mankind Pharma IPO | Udayshivakumar Infra IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹1,026.00 per share | ₹33.00 per share |
Issue Price (Upper) | ₹1,080.00 per share | ₹35.00 per share |
Issue Price (Final) | ₹1,080.00 per share | ₹35.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 13 shares | 428 shares |
Fresh Issue Size | 2,00,00,000 shares | |
Fresh Issue Size (Amount) | up to ₹66.00 Cr | |
OFS Issue Size | 4,00,58,844 shares | |
OFS Issue Size (Amount) | up to ₹4,326.36 Cr | |
Issue Size Total | 4,00,58,844 shares | 2,00,00,000 shares |
Issue Size Total (Amount) | up to ₹4,326.36 Cr | up to ₹66.00 Cr |
Mankind Pharma IPO opens on Apr 25, 2023, while Udayshivakumar Infra IPO opens on Mar 20, 2023. The closing date of Mankind Pharma IPO and Udayshivakumar Infra IPO is Apr 27, 2023, and Mar 23, 2023, respectively.
Mankind Pharma IPO | Udayshivakumar Infra IPO | |
---|---|---|
Anchor Bid Date | Apr 24, 2023 | Mar 17, 2023 |
Issue Open | Apr 25, 2023 | Mar 20, 2023 |
Issue Close | Apr 27, 2023 | Mar 23, 2023 |
Basis Of Allotment (Tentative) | May 03, 2023 | Mar 28, 2023 |
Initiation of Refunds (Tentative) | May 04, 2023 | Mar 29, 2023 |
Credit of Share (Tentative) | May 05, 2023 | Mar 31, 2023 |
Listing date (Tentative) | May 09, 2023 | Apr 03, 2023 |
Anchor Lockin End date 1 | Jun 02, 2023 | Apr 27, 2023 |
Anchor Lockin End date 2 | Aug 01, 2023 | Jun 26, 2023 |
Mankind Pharma IPO P/E ratio is 32.5, as compared to Udayshivakumar Infra IPO P/E ratio of 9.67.
Mankind Pharma IPO | Udayshivakumar Infra IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 79.00% | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 76.50% | 65.9% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 32.5 | 9.67 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹43263.60 Cr. | ₹193.75 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 27.60%% | 17.80%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 26.10%% | 20.71%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹33.20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 27.70%% |
In the Mankind Pharma IPO retail investors (RII) are offered 1,40,20,596 shares while in Udayshivakumar Infra IPO retail investors are offered 1,40,20,596 shares. Qualified institutional buyers (QIB) are offered 80,11,769 shares in Mankind Pharma IPO and 18,85,715 shares in Udayshivakumar Infra IPO.
Mankind Pharma IPO | Udayshivakumar Infra IPO | |
---|---|---|
Anchor Investor Reserveration | 1,20,17,652 shares | |
Market Maker Reserveration | ||
QIB | 80,11,769 shares | 18,85,715 shares |
NII | 60,08,827 shares | 56,57,142 shares |
RII | 1,40,20,596 shares | 1,13,14,285 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 2,80,41,192 shares | 1,88,57,142 shares |
Mankind Pharma IPO subscribed 15.32x in total, whereas Udayshivakumar Infra IPO subscribed 32.49x.
Mankind Pharma IPO | Udayshivakumar Infra IPO | |
---|---|---|
QIB (times) | 49.16x | 42.92x |
NII (times) | 3.80x | 64.08x |
Big NII (times) | 4.99x | 63.54x |
Small NII (times) | 1.41x | 65.14x |
RII (times) | 0.92x | 14.95x |
Employee (times) | ||
Other (times) | ||
Total (times) | 15.32x | 32.49x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|